Physicians Seek Unrestricted Coverage Of NaF-18 PET For Bone Metastasis
This article was originally published in The Pink Sheet Daily
Executive Summary
Imaging professional societies urge CMS to issue a final national coverage determination allowing use of the agent in cancer patients because of the shortage of Technetium-99m, the only bone imaging agent currently covered.